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Recessive mutations in DNAJC3, an endoplasmic reticulum (ER)-resident BiP co-
chaperone, have been identified in patients with multisystemic neurodegeneration
and diabetes mellitus. To further unravel these pathomechanisms, we employed a
non-biased proteomic approach and identified dysregulation of several key cellular
pathways, suggesting a pathophysiological interplay of perturbed lipid metabolism,
mitochondrial bioenergetics, ER-Golgi function, and amyloid-beta processing. Further
functional investigations in fibroblasts of patients with DNAJC3 mutations detected
cellular accumulation of lipids and an increased sensitivity to cholesterol stress, which
led to activation of the unfolded protein response (UPR), alterations of the ER-Golgi
machinery, and a defect of amyloid precursor protein. In line with the results of previous
studies, we describe here alterations in mitochondrial morphology and function, as a
major contributor to the DNAJC3 pathophysiology. Hence, we propose that the loss
of DNAJC3 affects lipid/cholesterol homeostasis, leading to UPR activation, β-amyloid
accumulation, and impairment of mitochondrial oxidative phosphorylation.
Keywords: proteomics, cholesterol-stress, mitochondria, DNAJC3, unfolded protein response (UPR)
INTRODUCTION
DnaJ Heat Shock Protein Family (Hsp40) Member C3 (DNAJC3, p58IPK) is an endoplasmic
reticulum (ER)-resident co-chaperone of BiP (GRP78, HSPA5), which transiently binds to a broad
range of newly synthesized proteins present in the ER to impede the misfolding of susceptible
domains. In its “rested” state, DNAJC3 is localized to the ER lumen. The N-terminus of the protein
Abbreviations: ER, endoplasmic reticulum; DNAJC3, DnaJ heat shock protein family (Hsp40) member C3; UPR, unfolded
protein response; PERK, protein kinase R (PKR)-like endoplasmic reticulum kinase; eIF2-α, eukaryotic initiation factor 2A;
Aβ, β-amyloid; mtDNA, mitochondrial DNA; MSS, Marinesco–Sjörgen syndrome; ATP/ADP, adenosine tri/di-phosphate.
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is able to directly bind to hydrophobic regions of misfolded
proteins present in the ER (Rutkowski et al., 2007). Once the
misfolded protein is bound to the N-terminus of DNACJ3,
further ATP-dependent interaction via the J-domain with BiP
supports the refolding of the misfolded protein (Oyadomari
et al., 2006). Additionally, activated DNAJC3 is thought to
downregulate the signaling of the unfolded protein response
(UPR) effector PERK [protein kinase R (PKR)-like endoplasmic
reticulum kinase], presumably by interaction with its cytoplasmic
domain (Yan et al., 2002). Dimerization of PERK via the
phosphorylation of eukaryotic initiation factor 2 alpha (eIF2-
α) reduces protein synthesis. Therefore, inhibition of PERK
dimerization by DNAJC3 increases protein synthesis and, during
periods of sustained UPR signaling, assists in returning the ER to
normal homeostasis. Dysregulation of this process may therefore
have toxic effects on cellular protein homeostasis. DNAJC3 affects
ER maintenance and apoptosis, particularly under conditions of
cellular stress, and it has been highlighted as a protective factor in
retinal neurons (Boriushkin et al., 2015).
Mutations in components of the UPR frequently cause
neurodegenerative diseases. Expression of mutant BiP lacking the
carboxyl terminal in a mouse model results in neurodegeneration
and severe muscle weakness, associated with aggregation of
proteins in the spinal cord alongside upregulation of UPR-
related proteins such as GRP94, calnexin and DDIT3 (Jin
et al., 2014). Similarly, transgenic mice expressing just 50% of
the wild-type BiP exhibit disruption of neural development,
defects of cortical neurons, and cerebellar abnormalities, while
homozygous loss-of-function mutations result in intrauterine
death in mice (Luo et al., 2006). Biallelic mutations in the BiP
co-chaperone SIL1 cause Marinesco–Sjögren syndrome (MSS)
in humans, a condition characterized by cataracts, early-onset
cerebellar ataxia, cognitive deficits, short stature, and progressive
vacuolar myopathy (Anttonen et al., 2005; Senderek et al., 2005;
Krieger et al., 2013). The MSS-mouse-model (woozy mouse)
lacks a functional Sil1 gene and replicates the human phenotype
(Buchkremer et al., 2016). Pathological examination of the
woozy mouse reveals the loss of Purkinje cells associated with
the accumulation of protein aggregates (Zhao et al., 2010),
a process found to be accelerated by additional suppression
of GRP170, another BiP interacting protein. This process is
partially ameliorated by loss of Dnajc3 (Zhao et al., 2010).
Furthermore, mutations in the BiP co-chaperone DNAJB2
have been found to be causative for distal hereditary motor
neuropathy, accompanied by an increased rate of SOD1 inclusion
formation in a neural cell model (Blumen et al., 2012). These
studies suggest a causal relationship between dysfunction of
protein processing and ER stress and the manifestation of
neurological diseases.
Autosomal recessive mutations in DNAJC3 have been first
reported to cause a neurological disorder in two Turkish families,
in which individuals presented with ataxia, upper-motor neuron
signs, demyelinating neuropathy, neuronal hearing loss, and
cerebral atrophy, complicated with early-onset type 2 diabetes
mellitus (MODY, OMIM #616192) (Synofzik et al., 2014) and
hypothyroidism in a distant relative of the originally reported
family (Bublitz et al., 2017). Moreover, isolated type 2 diabetes
mellitus has been reported in association with the heterozygous
c.712C > A (p.His238Asn) DNAJC3 mutation (Kulanuwat et al.,
2018); however, the same mutation was also observed in two
non-diabetic individuals in the study and has been seen at a low
frequency in the ExAC database, questioning the role of DNAJC3
as a dominant type 2 diabetes-associated gene. The p.His238Asn
mutation caused minor decrease in DNAJC3 expression, in
contrast to the apparent absence seen in the other reported cases.
Moreover, two DNAJC3 patients presenting with juvenile-onset
diabetes, short stature, hypothyroidism, neurodegeneration,
facial dysmorphism, hypoacusis, microcephaly, and skeletal bone
deformities were described (Lytrivi et al., 2021). Symptoms
resulting from mutations in DNAJC3 are partially overlapping
with phenotypes caused by mutations in DNAJB2 and SIL1, but
with the addition of diabetes (Bublitz et al., 2017).
The mechanisms underlying the pathophysiology of
mutations in other BiP co-chaperones such as SIL1 have
been extensively explored (Roos et al., 2014, 2016; Ichhaporia
et al., 2015; Kollipara et al., 2017; Phan et al., 2019), while
in contrast, there is little known about the precise cellular
mechanisms underlying the pathogenicity of DNAJC3 mutations.
Studies of primary patient-derived fibroblasts revealed loss
of the DNAJC3 protein and a structurally normal ER, and
upon ER stress induction, only minor changes were observed
in protein secretion and Ca2+ leakage (Synofzik et al., 2014).
Studies on DNAJC3-silenced rat and human β cells did not affect
insulin content and secretion but sensitized cells to ER stress,
triggering mitochondrial apoptosis (Lytrivi et al., 2021). To
further unravel this pathophysiological route here, we focused on
elucidating the pathomechanism of DNAJC3-related pathology
by performing proteomics in patient-derived primary fibroblasts,
a suitable model to study the etiology of rare neurological
diseases (Hentschel et al., 2021), and further investigation of the
suggested cellular phenotype.
RESULTS
Loss of Functional DNAJC3 Alters
Proteomic Signature of Human
Fibroblasts
Three human primary fibroblast lines carrying previously
reported pathogenic homozygous DNAJC3 mutations (two with
c.580C > T; p.Arg194∗ and one with a large deletion of
72 kb, spanning the UGGT2 gene NM_006260.5) alongside three
fibroblast lines of age-matched healthy controls were used for
our proteomics analysis. While the large deletion is spanning the
UGGT2 gene, which can raise concerns of possible overlapping
phenotypes, all DNAJC3 patients present with very similar
phenotypes. No disease has been so far associated with mutations
in the UGGT2 gene.
We detected 2,531 proteins in total with a minimum of two
unique peptides, of which 165 presented with a p-ANOVA < 0.05,
and from these, 24 were considered as altered in abundance
(12 are upregulated and 12 are downregulated). The most
significantly downregulated protein was DNAJC3, which was
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expressed at log2−2.66 in DNAJC3mut fibroblasts compared to
controls, thus confirming that the mutations lead to reduced
protein level and demonstrating the robustness of our untargeted
proteomic profiling approach. Thresholds were set to 2 standard
deviations from the median in either increase or decrease
to identify the most significantly altered proteins, which are
highlighted in Figure 1A.
Pathways associated with dysregulated proteins (KEGG,
Reactome, and DAVID libraries; Figure 1B) include lipid
homeostasis, specifically cholesterol metabolism, which was
perturbed in the DNAJC3mut cells (Figure 1B). Furthermore,
a dysregulation of ADP-ribosylation factor-binding protein
GGA1, involved in the processing of APP as an amyloid
precursor (von Arnim et al., 2006), was also observed.
Apolipoprotein O (APOOL) was increased, which has important
roles in mitochondrial lipids and prevention of mitochondrial
lipotoxicity (Montero et al., 2010; Turkieh et al., 2014), as well as
the Succinate dehydrogenase subunit B (SDHB), a major subunit
of mitochondrial respiratory complex II. We therefore identified
loss of DNAJC3 to be associated with a proteomic signature
of dysregulation of the ER, lipid and cholesterol metabolism,
dysregulation of mitochondrial cholesterol processing, and
induction of respiratory complex expression.
Loss of Functional DNAJC3 Results in
Cellular Lipid Increase
Prompted by the proteomic findings and the fact that altered
lipid homeostasis impacts a variety of cellular processes,
such as energy homeostasis, signaling, and on a general note
organelle homeostasis (Greenberg et al., 2011), we investigated
perturbed lipid homeostasis in our control and DNAJC3mut
fibroblasts. Levels of triglycerides and cholesterol esters were
investigated using the fluorescent neutral lipid dye 4,4-difluoro-
1,3,5,7,8-pentamethyl-4-bora-3a,4a-diaza-s-indacene (BODIPY)
and subsequent fluorescence microscopy. Results of these
studies showed an increased diffuse staining with perinuclear
accumulation and additional nuclear lipid-enrichment in
DNAJC3mut fibroblasts compared to the controls (Figures 2A,B),
supporting the concept of altered lipid homeostasis in cells
lacking functional DNAJC3.
As our proteomic data indicated a specific dysregulation
of cholesterol metabolism, we studied free cholesterol levels
using the filipin fluorescent staining technique (Figures 2C,D).
While we did not observe an increase in free cholesterol
under basal conditions, induction of ER stress with tunicamycin
resulted in a significantly greater accumulation of cholesterol
in DNAJC3mut fibroblasts compared to controls, demonstrating
that DNAJC3mut fibroblasts have functional dysregulation of
ER–cholesterol interactions. Treating cells with cholesterol and
an inhibitor of Acyl-CoA-: cholesterol acyltransferase (ACAT-I)
resulted in a significant increase of cholesterol in both controls
and DNAJC3mut fibroblasts (Figures 2C,D). This treatment
saturated cholesterol clearance capacity and put both DNAJC3mut
and control fibroblasts under hypercholesterolemic stress, with
only a non-significant slight increase observed in DNAJC3
patient cells compared to controls.
The Endoplasmic Reticulum Is More
Vulnerable Against Stress in DNAJC3mut
Fibroblasts
It was previously shown that in the presence of tunicamycin
or thapsigargin, which perturbs ER function and thus affects
FIGURE 1 | Comparative proteomic profiling results of DNAJC3-patient-derived fibroblasts versus control ones. (A) The volcano plot depicts all proteins identified in
fibroblasts, making a clear delimitation between the statistically significant and non-significant quantified proteins (p-ANOVA < 0.05; horizontal line). Proteins with
decreased abundances are represented in red, while the upregulated ones are highlighted in green color. (B) In silico analyses of proteomic findings included
pathway analysis of the regulated proteins. All proteins with altered abundances were searched using KEGG, DAVID, and Reactome databases for protein pathway
annotation. Vulnerable pathways (left Y-axis) were color-coded and referred to affected proteins (right Y-axis). Fold of regulation of the individual proteins is indicated
on the X-axis. GGA1, ADP-ribosylation factor-binding protein GGA1; SMARCB1, SWI/SNF-related matrix-associated actin-dependent regulator of chromatin
subfamily B member 1; SDHB, succinate dehydrogenase; SOAT1, Sterol O-acyltransferase 1; CHMP6, charged multivesicular body protein 6; ACADSB,
short/branched chain specific acyl-CoA dehydrogenase; ETHE1, persulfide dioxygenase ETHE1; SERPINE2, Glia-derived nexin; PLPP1, phospholipid phosphatase
1; PLIN2, perilipin-2; PTRH2, peptidyl-tRNA hydrolase 2; AARS, alanine–tRNA ligase, cytoplasmic; ALAD, delta-aminolevulinic acid dehydratase; SYNPO2,
synaptopodin-2; OCIAD2, OCIA domain-containing protein 2; SF3B4, splicing factor 3B subunit 4; HTATSF1, HIV tat-specific factor 1; APOOL, MICOS complex
subunit MIC27; ADD3, gamma-adducin; DNAJC3, DnaJ homolog subfamily C member 3.
Frontiers in Cell and Developmental Biology | www.frontiersin.org 3 October 2021 | Volume 9 | Article 710247
fcell-09-710247 September 30, 2021 Time: 15:28 # 4
Jennings et al. DNAJC3 Mutations Impact Mitochondria
FIGURE 2 | Lipid-level in DNAJC3-pathophysiology. (A) Results of BODIPY staining are shown for one representative fibroblast derived from controls (left panel) and
two from DNAJC3 patients (right panel). Notably, in DNAJC3mut cells, nuclear accumulated BODIPY staining can be observed (red arrows), which is absent in
controls. (B) Single-cell histogram analysis: comparison of intensity histograms for DNAJC3mut cells (green circles) with control cells (gray squares). Two samples per
group were analyzed and at least 10 individual cells were used per sample for statistical analyses. For each cell, a histogram analysis was performed giving the
frequency of intensity values in the specified ranges. Counts per intensity range were normalized to percentage values for individual cells before calculating the mean
and standard deviation for each group. DNAJC3mut fibroblasts tend to have more points with high fluorescence intensity than control cells, indicating an increased
level of BODIPY stained lipids and thus an agglomeration/accumulation of lipids in these cells. (C) Confocal microscope images of Filipin III staining are shown for
one representative fibroblast derived from controls and one DNAJC3 patient in the presence or absence of cholesterol or Tunicamycin. (D) Quantification of mean
Filipin III positive area relative to cell area (%) for DNAJC3mut and control fibroblasts. Both tunicamycin (Tunic) and cholesterol stress (Chol) treatments increase %
Filipin positive area relative to control (p < 0.01, Student’s t-test with Welch’s correction) in both DNAJC3mut and control, with * indicating statistical significance
between DNAJC3mut and control groups of the same treatment type.
the secretory machinery, DNAJC3 mutant fibroblasts exhibit
ER dysfunction (Synofzik et al., 2014). An increased sensitivity
against additional ER stress burden was identified in DNAJC3-
silenced rat and human β cells (Lytrivi et al., 2021). Notably,
several publications demonstrated that cellular cholesterol
accumulation leads to UPR activation (Feng et al., 2003;
Cunha et al., 2008; Fu et al., 2011). DNAJC3mut fibroblasts
present a higher tendency of cholesterol aggregation compared
to control cells (Figures 2C,D). Taking these findings into
consideration, and the fact that neurons (as the vulnerable
cellular population of the DNAJC3-phenotype) present with a
more pronounced sensitivity against both ER stress and lipid
accumulation (Jazvinscak Jembrek et al., 2015), DNAJC3mut
and control fibroblasts were further stressed by cholesterol
overload to exacerbate ER stress. Parallel reaction monitoring
(PRM) was employed to evaluate the respective activation
of the UPR (Figure 3A). Statistically significant increases
(p < 0.05) following cholesterol overload were observed for
targets in both patient and control fibroblasts. Remarkably, ATF3,
DDIT3, ERN1, PR15A, and XBP1 were significantly increased
in DNAJC3mut fibroblasts compared to controls (Figure 3A).
To further elucidate an increased sensitivity of DNAJC3mut
fibroblasts against additional ER stress burden, additional
immunoblot studies were carried out: BiP, major chaperone of the
ER and a key modulator of UPR (Dudek et al., 2009), along with
its co-chaperone GRP170 and SIGMAR1, SEC63, and HSP90.
We observed an increase in BIP, SEC63, and SIGMAR1 proteins
in DNAJC3mut fibroblasts compared to controls. Furthermore,
cholesterol treatment leads to a more significant increase of these
proteins in DNAJC3mut fibroblasts than controls, suggestive of
an increased vulnerability toward ER stress upon cholesterol
loading (Figures 3B,C). We observed a considerable increase in
eIF2α phosphorylation, a master regulator of protein translation
upon stress (Boye and Grallert, 2020), while PERK shows a mild
increase in DNAJC3mut fibroblasts after cholesterol-treatment
(Figures 3B,C), which constitutes a hallmark of ER stress and
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UPR activation. ATF4 shows a decrease in cholesterol-stressed
control fibroblasts in contrast with the increase observed in
DNAJC3mut cells after treatment (Figures 3B,C). Moreover,
ATF6, one of the main UPR branches, seems unaffected by
the loss of function of DNAJC3. Our combined proteomic and
immunoblot findings suggest that loss of DNAJC3 leads to a
very mild UPR activation with a slight increase of some UPR-
modulated proteins under basal conditions, while further stress
caused by cholesterol accumulation leads to an increase in




The upregulation of several proteins involved in mitochondrial
biogenesis observed in the DNAJC3mut proteome (Figure 1)
prompted us to examine the mitochondrial function in
DNAJC3mut fibroblasts. We evaluated mitochondrial function
and the structure of mitochondrial networks in control and
DNAJC3mut fibroblasts using a redox staining (Mitotracker),
with and without cholesterol treatment. Cholesterol treatment
induced a clear fragmentation of the mitochondrial network
in DNAJC3mut and control cells (Figure 4A), indicating
that cholesterol treatment induced combined ER/mitochondrial
stress. As network imaging by redox staining is dependent on
the membrane potential, differences in dye incorporation as a
result of cholesterol treatment may be caused by changes in
mitochondrial membrane potential. However, further studies
would be needed to clarify this.
Next, we investigated mitochondrial copy number in control
and DNAJC3mut fibroblasts under basal conditions and after
cholesterol treatment. Neither loss of DNAJC3 or cholesterol
treatment affected mtDNA copy number, despite the associated
changes in mitochondrial morphology (Figure 4B).
To further elucidate the effects upon loss of functional
DNAJC3 on mitochondria, immunoblot studies focusing on
expression of all five mitochondrial complexes were performed.
DNAJC3mut fibroblasts display a statistically significant increase
in complex I (NDUFB8), complex II (SDHB), complex III
(UQCRC2), and complex V (ATP5A) compared to controls,
suggestive of a oxidative phosphorylation (OXPHOS) defect.
Cholesterol treatment induces an increase in in mitochondrial
complexes in both control and patient fibroblasts (Figure 4C)
with a statistically significant increase of complexes I and III
in DNAJC3 cells compared to controls (Figure 4C). These
biochemical findings suggest that cholesterol accumulation leads
to secondary upregulation of the respiratory complexes in
DNAJC3mut and, less prominently, in control cells (Figure 4C).
To determine whether the upregulation observed in the
OXPHOS system has a functional effect on bioenergetic capacity,
we performed oxygen consumption studies by Seahorse assay.
DNAJC3mut cells have increased basal respiration compared to
controls, in accordance with the increased levels of mitochondrial
complexes. In contrast, cholesterol-treated DNAJC3mut and
control cells show a decrease in basal respiration, ATP-linked
respiration, and non-mitochondrial respiration compared to
mock-treated cells. The decrease in maximal respiratory capacity
after cholesterol treatment was greater in DNAJC3mut cells
compared to controls, suggesting that cholesterol treatment is
compromising the compensatory capacity of DNAJC3mut cells
(Figure 4D). Additionally, we can observe an increase in non-
mitochondrial respiration (Figure 4D) in DNAJC3mut cells
compared to controls, suggestive of the hindered bioenergetic
health of the cells. This type of respiration has been suggested
to increase in the presence of different stressors such as oxygen
reactive species (Dranka et al., 2010; Hill et al., 2012).
DNAJC3 Mutant Fibroblasts Have
Disrupted Regulation of Intracellular
Amyloid Precursor Protein
ER stress may lead to an accumulation of β-amyloid (Aβ)
and amyloid precursor protein (APP), and indeed stimulation
of expression of other DnaJ family BiP co-chaperones has
been shown to ameliorate the accumulation of Aβ in cellular
Alzheimer’s disease models (Evans et al., 2006; Mansson et al.,
2014). Moreover, impaired cholesterol homeostasis has been
previously linked to Aβ accumulation (Ledesma and Dotti,
2006). These previously reported findings prompted us to study
APP and Aβ in DNAJC3mut fibroblasts compared to controls.
Our findings show that cellular loss of functional DNAJC3
results in a significant increase of monomeric APP (Figure 5B).
Moreover, DNAJC3mut fibroblasts present two extra bands at
higher molecular weight corresponding to the immature and
mature dimeric form of APP (Figure 5B). Similar to DNAJC3mut
cells, cholesterol treatment in control cells leads to an increased
level of APP compared to the mock-treated controls but without
dimerization of APP (Figures 5A,B), suggesting that DNAJC3
loss impacts APP dimerization. The increase in the mature and
immature APP dimers after cholesterol treatment in DNAJC3mut
cells suggests that the additional ER stress triggered by cholesterol
treatment and cholesterol accumulation exacerbates this process.
It is also worth noting that cholesterol treatment of DNAJC3mut
fibroblasts has no impact on the monomeric APP (Figures 5A,B).
Next, we assessed the apoptosis in our cell models. Both
DNAJC3mut and control cells show similar levels of procaspase
(uncleaved caspase-3), while the cleavage product that indicate
caspase-3 (CASP3) activation increases in DNAJC3mut cells
(Figures 5A,B). Cholesterol treatment led to increased CASP3
activation in both patient and control cells, suggesting that the
increased stress burden of lipid accumulation induces apoptosis.
DNAJC3mut cells display increased immunoreactivity to anti-
Aβ antibody compared to control cells (Figure 5C). Cholesterol
treatment leads to a significant increase in controls, while patient
cells present a non-significant, smaller increase when compared
to mock-treated DNAJC3 cells. Interestingly, despite cholesterol
accumulation not significantly modifying the amount of Aβ
deposition in DNAJC3 cells, we can observe that it induces
a major change in the pattern of Aβ, which forms bigger
clusters, found mostly around the perinuclear and nuclear region
(Figure 5C). Cholesterol treatment of control cells does not
seem to induce a change in Aβ cluster size and pattern as seen
in treated mutant cells. Given that anti-Aβ staining does not
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FIGURE 3 | Endoplasmic reticulum (ER) stress in DNAJC3mut fibroblasts. (A) Mean values (two technical and two biological replicates for each sample type,
respectively) of PRM-based quantification of known ER stress-related proteins following treatment with either DMSO (mock) or soluble cholesterol + ACAT inhibitor in
patient and control fibroblasts, respectively. Cholesterol treatment and concomitant inhibition of cholesterol acyltransferase (ACAT; esterifies cholesterol) resulted in
pronounced ER stress in both DNAJC3mut and control fibroblasts. Notably, significantly greater increases in ER stress protein expression was seen following soluble
cholesterol treatment for ATF3 (p = 0.026), DDIT3 (p = 0.031), ERN1 (p = 0.049), PR15A (p = 0.028), and XBP1 (p = 0.003) in treated DNAJC3mut cells. Student’s
t-tests compared either mock-treated or cholesterol-treated control versus the correspondingly treated DNAJC3mut fibroblasts. Student’s t-test (n = 2) of changes
between mock-treated and cholesterol-treated expression levels is statistically significant between mock-treated DNAJC3mut versus control fibroblasts for ATF3
(Continued)
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FIGURE 3 | (Continued)
(p = 0.027), DDIT3 (p = 0.031), ERN1 (p = 0.049), PR15A (p = 0.029), and XBP1 (p = 0.0033). Targeted peptides were ATF3: NFLIQQIK; ATF6: EAQDTSDGIIQK;
DDIT3: VAQLAEENER; E2AK3: FLDNPHYNK; ERN1: FPNNLP; PR15A: GAALVEAGLEGEAR and XBP1: LLLENQLLR. (B) Results of immunoblot analysis of UPR
markers in two DNAJC3-patient-derived and three control cells (treated under the same conditions as for the PRM ER stress investigations) showing changes in
UPR markers in DNAJC3 cholesterol-treated cells, thus underlining the vulnerability of these cells to lipid accumulation. GAPDH was used to show equal loading.
(C) Densitometry analysis of the immunoblotting from panel (B). Graphs show mean±SD of triplicate samples (control fibroblasts and DNAJC3mut fibroblasts under
mock-treated and cholesterol-treated). For statistical analysis, Fisher’s LSD test was employed where ∗p ≤ 0.05, ∗∗p ≤ 0.01, ∗∗∗p ≤ 0.001 was considered as
statistically significant.
detect Aβ in controls cultured under basal conditions, cholesterol
treatment seems to trigger accumulation of Aβ even in controls.
This finding in turn supports the concept that lipid buildup leads
to an increase of Aβ peptide production (Shobab et al., 2005).
Intracellular trafficking of APP through Golgi is crucial for the
generation of Aβ (Choy et al., 2012). Thus, we investigated Golgi
integrity in fibroblasts using immunofluorescence (Figure 5C).
Our data show a tightly compacted Golgi in perinuclear
localization in control cells while some DNAJC3mut cells present
with a more sparce Golgi. Cholesterol treatment does not have
any structural effects in controls, while DNAJC3mut display a
scattered Golgi, suggesting a vulnerability of this compartment
upon lipid loading in patient cells.
DISCUSSION
Bi-allelic loss-of-function mutations in DNAJC3, encoding
a co-chaperone of BiP, one of the major chaperones of
the ER, have been shown to cause neurodegeneration with
early-onset ataxia, upper-motor-neuron signs, demyelinating
neuropathy, and cerebral atrophy associated with diabetes
mellitus (Synofzik et al., 2014). Mutations in genes encoding
BiP co-chaperones, localized in the ER or proteins involved
in the UPR-modulation have been associated with central and
peripheral nervous system abnormalities and non-autoimmune
type insulin-dependent diabetes. For example, SIL1 is one
of the main co-chaperones of BiP involved in the ATP-
ADP cycle, and recessive SIL1 mutations have been associated
with MSS characterized by congenital cataracts, cerebellar
ataxia, progressive muscle weakness, and delayed psychomotor
development as well as axonal degeneration and disintegration
of the neuromuscular junctions (Phan et al., 2019). Clinically
overlapping features have been found in patients with recessive
DNAJC3 mutations (Synofzik et al., 2014). Remarkably, a
modulating function of DNAJC3 expression in cerebellar
degeneration has been demonstrated in the molecular etiology
of MSS (Zhao et al., 2010), demonstrating a crucial role of
this co-chaperone in neuronal maintenance. Other examples are
Wolfram syndrome, caused by mutations in WFS1 presenting
with early-onset ataxia, cognitive deficits, and hearing loss, thus
also including clinical hallmarks of the phenotype associated
with DNAJC3 mutations (Khanim et al., 2001) and Wollcot-
Rallison syndrome, an autosomal recessive disorder caused by
mutations in eukaryotic translation initiation factor 2-alpha
kinase 3 (E2AK3), characterized by insulin-dependent diabetes,
growth retardation, and intellectual disability (Delepine et al.,
2000). In addition, a mutation in the Sec61a1 gene (p.Tyr344His)
results in excessive ER stress and apoptosis of pancreatic β
cells in C57BL/6 mice, resulting in diabetes and hepatosteatosis
(Linxweiler et al., 2017).
To obtain insights into the mechanism underlying the
pathophysiology of mutations in DNAJC3, unbiased proteomic
studies utilizing patient-derived fibroblasts were carried out
(Figure 1). While fibroblasts are not the primary site of clinical
manifestation, these cell models have been previously shown to
be suitable to study the etiology of rare neurological diseases
(Hentschel et al., 2021) and show very similar levels of DNAJC3
expression to peripheral nerve (Supplementary Figure 1).
Results of this profiling suggest that lipid metabolism is affected
by DNAJC3mut mutations (Figure 1) as Sterol-O-acyltransferase
1 (SOAT1), an enzyme responsible for the esterification of fatty
acids, especially cholesterol (Das et al., 2008), was found to be
decreased. Lower levels of SOAT1 were previously linked to a
hindered cholesterol clearance suggesting that DNAJC3-deficient
cells present an accumulation of cholesterol (Tabas, 2002; Luo
et al., 2010). We detected decreased abundance of Periplin 2
(PLIN2), an enzyme involved in lipid droplet formation, which
has been linked to acute cholesterol accumulation (Makino et al.,
2016), further suggesting a lipid dysregulation in fibroblasts
lacking functional DNAJC3. Our functional data on cholesterol
and lipid accumulation using immunofluorescence bring further
evidence of lipid accumulation in DNAJC3mut cells (Figure 2).
Cholesterol homeostasis is essential for neuronal functioning and
brain development, while perturbed cholesterol metabolism is
a major pathophysiological mechanism in neurological diseases
such as Alzheimer’s disease and Niemann-Pick type C disease, an
autosomal recessive storage disorder, characterized by abnormal
sequestration of unesterified cholesterol in cells (Fernandez et al.,
2009; Marquer et al., 2014).
Label-free proteomics revealed that DNAJC3 is the most
decreased protein in the mutant fibroblasts in alignment with
previously published results (Synofzik et al., 2014), emphasizing
the sensitivity of our proteomic profiling approach. Although
DNAJC3 has been widely acknowledged in the attenuation of
proteins involved in the initial ER response (Schorr et al., 2015),
changes in ER morphology or increased ER calcium leakage
were not described previously in the context of the underlying
pathophysiology (Synofzik et al., 2014). However, an increased
sensitivity against additional ER stress burden was identified in
DNAJC3-silenced rat and human β cells (Lytrivi et al., 2021).
In accordance with these previous observations, our findings
suggest only a minor UPR-activation mirrored by the altered
abundance of ER-stress-related proteins (Figure 3). DNAJC3
has been shown to bind the kinase domain of PERK (also
called EIF2AK3), in order to terminate the first phase of ER
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FIGURE 4 | Study of mitochondrial integrity in DNAJC3 pathophysiology. (A) Mitotracker staining in DNAJC3mut and control fibroblasts revealed a more fragmented
mitochondria in patient cells with reduced staining in DNAJC3mut cells compared to controls. One representative cell is presented per condition, whereby 30 cells
have been studied for each of the analyzed conditions. (B) Mean mitochondrial DNA copy number quantitative real-time PCR relative abundances (two technical and
two biological replicates for each sample type, respectively) show that cholesterol overload results in a mild increase of mtDNA copy in control but not in DNAJC3mut
fibroblasts. (C) Immunoblot studies of the mitochondrial respiratory chain complexes I–V (left panel) revealed a significant increase of complex I and II as well as IV
and V in DNAJC3mut cells, which was more pronounced in DNAJC3mut cells after cholesterol-treatment; ∗t-test < 0.05. Level of the proteins representing the
different complexes have been normalized to VDAC1. Densitometry analysis of the Western blotting results is represented in the right panel. (D) Mean oxygen
consumption rate (OCR) of two biological replicates for each condition (each consisting of ≥12 technical replicates). Statistical significance indicated between treated
versus non-treated DNAJCmut or control cells, and between DNAJCmut versus control cells under either treated or non-treated conditions. Student’s t-test,
∗p < 0.05.
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FIGURE 5 | Analysis of amyloid accumulation in DNAJC3mut cells. (A) Immunoblotting of APP reveals increased levels of this protein monomer in DNAJC3mut cells,
while cholesterol treatment leads to a further increase only in control cells. (B) Densitometry analysis of immunoblotting from panel (A). Graphs show ±SD of
triplicate samples, and all data were normalized to GAPDH. The mature and immature APP dimers on immunoblotting are present only in the DNAJC3mut cells and
cholesterol treatment increases the amount of these proteins, which are further cleaved to form the β-amyloid (Aβ) fragment. Cholesterol treatment induced an
activation of caspase-3 protein (corresponding to the 17-kDa fragment), indicating an increase in apoptosis Student’s t-test, *p < 0.05. (C) Representative Aβ and
GOLOGA1 staining in control and DNAJC3mut cells in the presence and absence of cholesterol. Bar plots represent the corrected total florescence measured for the
Aβ in three DNAJC3mut and three controls in mock and cholesterol-treated cells. Immunofluorescence analysis shows that DNAJC3mut fibroblasts present an
increase in Aβ while the cholesterol treatment exacerbates the accumulation of the toxic fragment in patient cells. The cholesterol treatment leads to a slight increase
in the Aβ in control cells as well; *t-test < 0.05.
stress (Yan et al., 2002). Given that DNAJC3mut fibroblasts show
slightly increased PERK expression (Figures 3B,C), its activation
is presumably not terminated by DNAJC3 loss of function.
The ER has been described to tightly regulate the lipid
metabolism as it is involved in the synthesis of phospholipids,
re-esterification of sterols, and lipid-membrane biosynthesis
(Volmer and Ron, 2015). Cholesterol accumulation disturbs
the free cholesterol:phospholipid ratio on the normally fluid
ER membrane, thus leading to the activation of ER stress
(Feng et al., 2003). The impaired lipid/cholesterol metabolism
in DNAJC3mut cells was demonstrated by our Filipin-III and
BODIPY staining affects ER maintenance and results in irregular
lipid accumulation, supporting the concept of perturbed ER
membrane structure. Additionally, induction of ER stress with
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tunicamycin leads to an increase in cholesterol accumulation in
both control and patient cells, but with a more pronounced effect
in DNAJC3 cells. We detected increased vulnerability of the ER
in DNAJC3mut cells after cholesterol treatment (Figure 3) similar
to a previous study on DNAJC3-silenced rat and human β cells
(Lytrivi et al., 2021). These findings provide evidence that lipid
accumulation leads to ER stress activation, which is exacerbated
in DNAJC3mut patient cells.
There are numerous contact sites between ER and
mitochondria [Mitochondria Associated ER Membranes
(MAM)], which may enable cholesterol influx from the ER to
the mitochondria (Arenas et al., 2017). The interaction of ER
and mitochondrial membranes links mitochondrial dysfunction
to ER stress. Our proteomic profiling data indicated that
DNAJC3mut fibroblasts present with mitochondrial alterations.
We found that proteins involved in the maintenance of
mitochondrial architecture and biogenesis (APOOL), fatty
acid metabolism (ACDSB), or mitochondrial respiratory chain
complexes (such as complex II, SDHB) are dysregulated as a
results of DNAJC3 loss, suggestive of mitochondrial dysfunction.
Further investigation in DNAJC3mut fibroblasts revealed
significantly increased level of mitochondrial respiratory chain
subunits (except for complex IV) (Figure 4C) in line with the
significant increase in basal respiration, which can be attributed
to a possible increase in cellular energy demands. Mitochondrial
respiration has been shown previously to increase due to ER
stress (Balsa et al., 2019) and can constitute a pro-survival
mechanism from ER stress (Knupp et al., 2019).
Mitochondria are organelles sparse in cholesterol; however,
the transport of this lipid to the inner mitochondrial membrane
via MAM proteins is tightly regulated and of physiological
importance (Rone et al., 2009; Marriott et al., 2012). Cholesterol
treatment of control and DNAJC3mut fibroblast cells induced
clear mitochondrial fragmentation altering the dynamics of the
mitochondrial membranes (Figure 4) and leads to an increase in
OXPHOS complexes in control cells, and an even greater increase
in Complex I and III in DNAJC3mut cells when compared
to controls (Figure 4C). These changes have been previously
associated with depletion of glutathione (GSH) (Fernandez
et al., 2009). An increase of complex III has been associated
with lower GSH levels and with an increase in mitochondrial
depolarization, which leads to the release of Cytochrome c and
activation of caspase-3 (Fernandez et al., 2009). Lipid overload
increases caspase-3 levels in both control and patient cells,
showing that cholesterol accumulation is a pro-apoptotic factor
(Figures 5A,C). This may suggest that cholesterol overload
exacerbates the DNAJC3mut phenotype to further deplete GSH
levels, finally leading to apoptosis. Further experiments focusing
on apoptosis key factors would be needed to determine exactly the
role of DNJC3 and lipid accumulation in cell death promotion.
These findings accord with previous studies in DNAJC3-silenced
rat and human β cells (Lytrivi et al., 2021), and in turn
could also explain why non-mitochondrial respiration increases
dramatically in DNAJC3mut fibroblasts and in cells exposed to
cholesterol (Figure 4D).
Endoplasmic reticulum stress, mitochondrial dysfunction, and
cholesterol metabolism are thought to cause type 2 diabetes
mellitus via activation of inflammatory pathways thereby
inhibiting insulin secretion. Cholesterol treatment of pancreatic
β cells triggers apoptosis and ER stress, while inhibition
of cholesterol prevents β-cell apoptosis. However, DNAJC3-
silencing rat and human β cells did not result in perturbed insulin
production (Lytrivi et al., 2021).
β-Amyloid regulates the cholesterol flux to the mitochondria
and interacts with components of the OXPHOS and thus
participates in the molecular etiology of neurodegenerative
diseases (Fernandez et al., 2009; Barbero-Camps et al., 2014).
Disturbed cholesterol homeostasis has also been shown to affect
Aβ accumulation, as cholesterol enhanced the aggregation of
Aβ by inhibiting the degradation of this peptide (Yip et al.,
2001; Ehehalt et al., 2003). Additionally, the C terminal APP
fragment has been shown to regulate lipid homeostasis by
acting as a cholesterol sensor in the membrane, contributing
to the early pathology in Alzheimer’s disease (DelBove et al.,
2019; Montesinos et al., 2020). Here, we detected the altered
level of GGA1 (Figure 1), a Golgi protein that controls APP
processing (von Arnim et al., 2006) and Golgi alterations
(Figure 5C), suggesting that Aβ accumulation (a known hallmark
in different neurodegenerative diseases) might be involved in
cellular perturbations in DNAJC3mutcells. Indeed, DNAJC3mut
cells present with an increase in APP, which is not further
affected by cholesterol treatment (Figure 5). We also detected
two additional bands in the immunoblot corresponding to the
mature and immature APP dimer (N- and O-glycosylated forms
of APP dimers) (Isbert et al., 2012), supporting the concept of Aβ
accumulation in DNAJC3mut cells, which may further contribute
to the neurodegenerative phenotype.
In summary, we show that DNAJC3 mutations affect
cellular lipid metabolism leading to (i) altered ER sensitivity
toward stress burden, (ii) mitochondrial vulnerability, and
(iii) Aβ accumulation. Neurons are particularly vulnerable to
dysfunction of these pathways, which may explain the specifically
neurological manifestation of DNAJC3 deficiency. Hence, our
study provides molecular and mechanistic insights into the
underlying pathophysiology of this rare disease and informs of
the physiological function of DNAJC3.
MATERIALS AND METHODS
Cell Culture
We studied two fibroblast lines carrying a homozygous
c.580C > T (NM_006260.4, p.Arg194∗) premature stop mutation
in DNAJC3, one line having a large homozygous deletion of 72 kb
spanning DNAJC3 (and the adjacent UGGT2 gene), and control
fibroblasts from three healthy donors, age and sex matched
(Synofzik et al., 2014). Both mutations result in a 50% truncation
of DNAJC3 mRNA (Synofzik et al., 2014). Patient fibroblasts
were cultured in Dulbecco’s Modified Eagle Media (DMEM)
containing 4.5 g/L glucose, L-glutamine (Gibco) and phenol red
supplemented with 10% fetal bovine serum (FBS) (Gibco) and
1% (v/v) penicillin/streptomycin solution at 37◦C in a 5% CO2
atmosphere. Fibroblasts were grown to 80% confluence prior to
harvesting or applying treatment.
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Cholesterol Stress Treatment
Fibroblasts (patient and controls) were stressed by supplementing
the growth media with 10 µg/ml Sandoz 58-035 (Sigma-
Aldrich) (solubilized in DMSO), an inhibitor of Acyl-CoA-:
cholesterol acyltransferase (ACAT-I), for 6 h followed by further
supplementation with 30 µg/ml of water-soluble cholesterol
(Sigma-Aldrich). After 18 h of exposure to the Sandoz 58-035 and
cholesterol, the stress treatment is considered complete; this is
referred to now only as “Cholesterol-treated.” Patient and control
fibroblasts were separately mock-treated with 0.1% DMSO and
used as controls, referred to as “mock-treated.”
Tunicamycin Treatment of Fibroblasts
Fibroblasts were treated for 18 h with 4 µg/ml Tunicamycin
(Sigma-Aldrich). The stock solution of Tunicamycin was
prepared using DMSO; thus, control and patient cells were
treated with the same amount of DMSO as the Tunicamycin-
treated cells and are referred to as “mock treated.”
Label Free LC-MS/MS Analysis
Reagents
Ammonium hydrogen carbonate (NH4HCO3), anhydrous
magnesium chloride (MgCl2), guanidine hydrochloride
(GuHCl), iodoacetamide (IAA), and urea were purchased from
Sigma-Aldrich, Steinheim, Germany. Tris base was obtained
from Applichem Biochemica, Darmstadt, Germany and sodium
dodecyl sulfate (SDS) was purchased from Carl Roth, Karlsruhe,
Germany. Dithiothreitol (DTT) and EDTA-free protease
inhibitor (Complete Mini) tablets were obtained from Roche
Diagnostics, Mannheim, Germany. Sodium chloride (NaCl)
and calcium chloride (CaCl2) were from Merck, Darmstadt.
Sequencing grade modified trypsin was from Promega, Madison,
WI USA. Benzonase R© Nuclease was purchased from Novagen.
Bicinchoninic acid assay (BCA) kit was acquired from Thermo
Fisher Scientific, Dreieich, Germany. All chemicals for ultra-pure
HPLC solvents such as formic acid (FA), trifluoroacetic acid
(TFA), and acetonitrile (ACN) were obtained from Biosolve,
Valkenswaard, Netherlands.
Cell Lysis, Sample Clean-Up, and Proteolysis
Fibroblasts of patients with DNAJC3 mutations (see above) and
controls were processed independently. Cells were lysed in 100 µl
of 50 mM Tris–HCl (pH 7.8) buffer containing 150 mM NaCl,
1% SDS, and EDTA-free protease inhibitor (Complete Mini) on
ice for 15 min. Then samples were centrifuged for 5 min at 4◦C
and 6,000 × g and the protein concentration was determined by
BCA assay (according to the manufacturer’s protocol). Cysteines
were reduced by the addition of 10 mM DTT and samples were
incubated at 56◦C for 30 min, followed by alkylation of free
thiol groups with 30 mM IAA at room temperature (RT) in the
dark for 30 min.
Sample preparation was performed using filter-aided sample
preparation (FASP) with some minor changes: 100 µg of
protein lysate was diluted 10-fold with freshly prepared 8
M urea/100 mM Tris-HCl buffer (pH 8.5) (Burkhart et al.,
2012; Kollipara and Zahedi, 2013), placed on PALL microsep
centrifugal device (30 kDa cutoff), and centrifuged at 13,500 × g
at RT for 20 min. Three washing steps were carried out with
100 µl of 8 M urea/100 mM Tris–HCl (pH 8.5) and then
the buffer was exchanged by washing the device thrice with
100 µl of 50 mM NH4HCO3 (pH 7.8). One hundred microliters
of digestion buffer [trypsin (Promega) (1:25 w/w, protease to
substrate), 0.2 M GuHCl, and 2 mM CaCl2 in 50 mM NH4HCO3
(pH 7.8)] was added to the concentrated proteins, and the
samples were incubated at 37◦C for 14 h. Resulting tryptic
peptides were recovered by centrifugation with 50 µl of 50 mM
NH4HCO3 followed by 50 µl of ultra-pure water, and the
resulting peptides were acidified [pH < 3 by addition of 10% TFA
(v/v)]. All digests were quality controlled as described previously
(Burkhart et al., 2012).
LC-MS/MS Measurement and Data Analysis
One microgram of each sample was measured using an Ultimate
3000 nano RSLC system coupled to an Orbitrap Fusion Lumos
mass spectrometer (both Thermo Scientific) and analyzed in a
randomized order to minimize systematic errors. Peptides were
preconcentrated on a 100 µm × 2 cm C18 trapping column
for 10 min using 0.1% TFA (v/v) at a flow rate of 20 µl/min
followed by separation on a 75 µm × 50 cm C18 main column
(both Pepmap, Thermo Scientific) with a 120-min LC gradient
ranging from 3 to 35% of 84% ACN, 0.1% FA (v/v) at a flow rate
of 250 nl/min. MS survey scans were acquired in the Orbitrap
from 300 to 1,500 m/z at a resolution of 120,000 using the
polysiloxane ion at m/z 445.12002 as lock mass (Olsen et al.,
2005), an automatic gain control target value of 2.0 × 105 and
maximum injection times of 50 ms. Top 15 most intense signals
were selected for fragmentation by HCD with a collision energy
of 30% and MS/MS spectra were acquired in the Iontrap using
an automatic gain control target value of 2.0 × 105, a maximum
injection time of 300 ms, a dynamic exclusion of 15 s.
Data analysis was performed using the Progenesis LC-MS
software from Non-linear Dynamics (Newcastle upon Tyne,
United Kingdom). Raw MS data were aligned by Progenesis,
which automatically selected one of the LC-MS files as reference.
After automatic peak picking, only features within retention
time and m/z windows from 0 to 120 min and 300–1,500
m/z, with charge states +2, +3, and +4 were considered
for peptide statistics and analysis of variance (ANOVA) and
MS/MS spectra were exported as peak lists. Peak lists were
searched against a concatenated target/decoy version of the
human UniProt database (downloaded on July 22, 2015
containing 20,273 target sequences) using Mascot 2.4 (Matrix
Science, Boston, MA, United States), MS-GF+, X!Tandem,
and MyriMatch with the help of searchGUI 3.2.5 (Vaudel
et al., 2011). Trypsin was selected as enzyme with a maximum
of two missed cleavages, carbamidomethylation of Cys was
set as fixed, and oxidation of Met was selected as variable
modification. MS and MS/MS tolerances were set to 10 ppm and
0.5 Da, respectively.
To obtain peptide-spectrum match and to maximize the
number of identified peptides and proteins at a given quality,
we used PeptideShaker software 1.4.0 (Vaudel et al., 2015).
Combined search results were filtered at a false discovery rate
(FDR) of 1% on the peptide and protein level and exported
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using the PeptideShaker features that allow direct re-import of
the quality-controlled data into Progenesis. Only proteins that
were quantified with unique peptides were exported. For each
protein, the average of the normalized abundances (obtained
from Progenesis) from the analyses was calculated in order to
determine the ratios between the patient and control fibroblast
lysates. Only proteins that were (i) commonly quantified in all the
replicates with (ii) one unique peptide, (iii) an ANOVA p-value
of ≤0.05 (Progenesis), and (iv) an average log2 ratio ≤ −1.17
or ≥1.7 were considered as dysregulated.
Pathway analysis on the label-free proteomics data was
performed using GO term analysis (biological function)
enrichment utilizing UniProt (available on www.uniprot.com).
Parallel Reaction Monitoring of Unfolded
Protein Response
The synthetic isotopic labeled (SIL) peptides were synthesized
in-house and absolute quantified using amino acid analysis
(AAA), which was performed as previously described (Nguyen
et al., 2019). Tryptic peptides from cholesterol-treated and mock-
treated DNAJC3mut and control cells were obtained via FASP
as described in the previous section. For the measurements,
between 212.9 and 1,907.5 amol of the SIL peptides was spiked
in each sample containing ∼1 µg of total tryptic peptides. The
amounts and sequence of the spiked-in peptide are listed in
Supplementary Table 1. For this experiment, we have employed
two DNAJC3mut patient cell lines from which one has a
homozygous c.580C > T (NM_006260.4, p.Arg194∗) premature
stop mutation in DNAJC3 and one has a large homozygous
deletion of 72 kb spanning DNAJC3 and two age- and sex-
matched controls.
Liquid Chromatography and Mass Spectrometry
For the separation and detection of peptides, an Ultimate 3000
Rapid Separation Liquid Chromatography (RSLC) nano system
equipped with ProFlow flow control device was coupled to an
Orbitrap Fusion Lumos Tribrid Mass Spectrometer equipped
with a nano-electrospray ion source (all from Thermo Scientific,
Bremen, Germany). The peptide separation was performed
as described previously (Nguyen et al., 2019). The nano-
electrospray ion source was run using positive ion mode at a
spray voltage of 1,800 V. The mass detection and quantification
were performed with the normalized collision energy at 32%,
automated gain control (AGC) target value at 2× 105, resolution
at 240,000, isolation width at a mass-to-charge value of 0.4, and
injection time at 600 ms.
Data Analysis
Skyline 64-bit version 3.7.0.11317 (MacLean et al., 2010) was used
to generate methods and analyze the raw data after measurement.
All generated data were reviewed and integrated manually. The
choice of peptide as well as the monitored fragments were
adapted from Nguyen et al. (2019). The light-to-heavy ratio
was built from the total area of all monitored fragments of
endogenous peptides (light) and SIL peptides (heavy). All the
measurements were performed with two technical replicates.
Mitochondrial Network Analysis
Mitotracker-redTM (MTR) (ThermoFisher), a membrane
potential-sensitive dye, was used to label the mitochondria in
fibroblasts. Cells were seeded to glass-bottomed dishes 24 h
prior to cholesterol stress treatment. Fibroblast growth media
was aspirated, and cells were incubated in staining media
constituted of minimal essential medium (Gibco), without
phenol-red, 10% FBS, and 75 nM MTR for 30 min at 37◦C prior
to imaging.
Imaging of the mitochondrial network was performed
using a Nikon A1R confocal microscope to capture three-
dimensional stacks of images, which were then processed to




For this experiment, we use two DNAJC3mut patient cell
lines, one with homozygous c.580C > T (NM_006260.4,
p.Arg194∗) premature stop mutation in DNAJC3 and the other
a large homozygous deletion of 72 kb spanning DNAJC3,
with two age- and sex-matched healthy controls. The oxygen
consumption rate (OCR) of fibroblasts was measured using an
XF96 Extracellular Flux Analyzer (Seahorse Bioscience, Agilent
Technologies). Fibroblasts were seeded into wells of the 96-well
cell culture microplate (Seahorse Bioscience) in 80 µl for 24 h
prior to cholesterol stress treatment in the microplate. After
this, cell media was replaced with 180 µl of bicarbonate-free
DMEM and incubated for 30 min. Supplementation of the
media with oligomycin, carbonyl cyanide-p-trifluoromethoxy-
phenylhydrazone (FCCP), rotenone, and antimycin allows the
determination of oxygen consumption rates attributable to
basal respiration, proton leakage, maximal respiratory capacity,
and non-mitochondrial respiration. ATP-linked respiration
and reserve capacity were also calculated. Inhibition of ATP
synthase by supplementation of media with oligomycin allows
the calculation of ATP-synthesis-linked oxygen consumption.
Subsequent supplementation with the uncoupling agent
maximizes the respiratory rate. OCR levels were normalized
to cellular mass, estimated by total well protein measured
by Bradford assay.
Quantification of Mitochondrial DNA
Copy Number
The relative mtDNA copy number per cell was quantified by a
multiplex Taqman (Bio-rad 4369510) qPCR assay by amplifying
MT-ND1 (mitochondrial encoded gene) and B2M (nuclear
encoded gene) with a CFX96TM Real-Time PCR Detection
System (Bio-Rad) following the protocol described previously
(Bartsakoulia et al., 2016). The primers used for template
generation of standard curves and the qPCR reaction are as
follows B2M: Fw-CACTGAAAAAGATGAGTATGCC, Rv-AA
CATTCCCTGACAATCCC; MTND1: Fw-AACA TTCCCTGA
CAATCCC, Rv-AACATTCCCTGACAATCCC. Copies per
microliter of each template were standardized to 1 × 1010 and
a 10-fold dilution series was amplified, with a DNA negative
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control on each plate. This was performed in 20 µl reactions in
a 96-well plate (Bio-Rad 5496), sealed using microplate “B” plate
sealers (VWR 391-1293). The reaction mixture was composed
of: 5 µl× 5× Taqman (Bio-rad 4369510), 0.4 µM of reverse and
forward primers, 25–50 ng of DNA template, 0.2 µl of MyTaq
HS DNA polymerase (Bioline BIO-21112), and PCR-grade
autoclaved sterile deionized water (to make up 20 µl of reaction
mixture). The cycling conditions were as follows: (1) initial
denaturation at 95◦C for 3 min, (2) 40 cycles of denaturation
at 95◦C for 10 s, and (3) annealing and extension at 62.5◦C for
1 min. The relative mtDNA copy number was calculated using
the 1Ct data following the equation: CopyNumber = 2 (2−1Ct)
where Delta Ct (1Ct) equals the sample Ct of the mitochondrial
gene (MTND1) subtracted from the sample Ct of the nuclear
reference gene (B2M).
Immunoblot Analyses
Whole protein extracts of cholesterol- and mock-treated
fibroblasts were prepared by lysing cells with RIPA buffer
(Sigma Aldrich) containing a protease inhibitor cocktail (Roche).
Proteins were separated by utilizing Bis-Tris Gels (Invitrogen)
and transferred to PVDF membranes (Invitrogen). Membranes
were blocked for 2 h at room temperature with 5% milk in PBS-
T and incubated with primary antibodies at 4◦C overnight. The
primary antibodies and dilutions used are as follows: mouse anti-
APP A4 1:1,000 (Merck-Millipore), mouse anti-GRP78 1:2,000
(BD Biosciences), rabbit anti-CASP3 1:1,000 (AB clonal), mouse
anti-GAPDH 1:2,000 (Abcam), mouse anti-VDAC1 1:1,000
(Abcam), and mouse anti-total OXPHOS antibody cocktail
1:1,000 (Abcam). Protein signals were detected with a Super
SignalTM West Pico PLUS (Thermo Scientific) kit according to
the manufacturer’s protocol.
Immunofluorescence Studies
For imaging amyloid protein distribution and the Golgi network,
cells were grown on coverslips and then fixed with 4%
formaldehyde for 15 min at room temperature. Excessive
formaldehyde was removed, and samples washed thrice with
PBS before permeabilization with 0.5% Triton X in PBS
for 10 min at room temperature and then blocked with
1% BSA for 1 h at room temperature. Next, cells were
washed thrice with 1 ml of PBS and then incubated at 4◦C
overnight with an anti-Golgin-97 (rabbit polyclonal, GeneTex)
and anti-beta-amyloid (mouse monoclonal, DE2B4, Abcam)
primary antibodies. Excessive primary antibody was removed
by washing three times with 1 ml of PBS. Fluorescently
labeled antibodies rabbit Alexa Fluor 488 and mouse Alexa
Fluor 594 (both Thermo Fisher Scientific) diluted in 1% BSA
in PBS were added to the samples and incubated at room
temperature for 1 h. Samples were washed finally three times
with PBS and once very briefly with water and mounted
onto microscope slides using ProLong Gold Antifade Mountant
with DAPI (Thermo Fisher Scientific). Imaging was performed
using a Nikon A1R confocal microscope and acquired images
were further analyzed using the open source image-processing
package in Fiji.
Cellular Cholesterol and Lipid
Quantification Using Florescence
Microscopy
To visualize lipid loading in our cells, we have employed Filipin
and BODIPY staining. Filipin III was employed to specifically
visualize cholesterol deposits in our cell models.
Cell culture medium was removed, and cells were gently
washed thrice with 1 × PBS (room temperature). Next, 100 µl
of 4% formaldehyde was added to each coverslip and incubated
for 15 min at room-temperature. After the formaldehyde has
been removed, cells were again washed thrice with 1 × PBS
(room-temperature). Cells were next incubated with 1 ml of
1.5 mg/ml glycine at room temperature for 10 min. Filipin
III from Streptomyces filipinensis (Sigma-Aldrich F4767) was
added on cells (125 µg/ml) for 2 h at room temperature.
Cells were next rinsed three times with PBS and slides were
mounted using ProLong Gold Antifade Mountant (Thermo
Fisher Scientific). Imaging was performed using a Leica confocal
microscope (excitation approximately 360 nm and emission
approximately 480 nm).
Data analysis was performed using Fiji. Two thresholds were
set; the higher one to include only filipin-positive areas, and
the lower one to also include areas of cellular autofluorescence
as a measure of total cellular area. From this percentage,
filipin positivity relative to cellular area was calculated for
each image, and the mean was determined for all images of
the fibroblast/treatment combination to give the percentage
filipin positivity per combination. A minimum of 55 cells per
combination were employed for quantification.
BODIPY (493/503; green solution; Life technologies, catalog
# D-3922) was added followed by an incubation overnight at
4◦C in the dark. The next day, BODIPY was removed, and
cells were washed three times with 200 µl of PBS and stored at
4◦C until microscopic inspection was carried out. Fluorescence
measurements were performed on a modified Leica TCS SP8
CARS laser scanning microscope using a 25× water immersion
objective [Fluotar VISIR 25x/0.95 WATER, for full description
of the system see (Ebersbach et al., 2018)]. BODIPY fluorescence
was excited at 488 nm and detected at 495–600 nm with a
hybrid detector. Specifications of the hybrid detectors are given
by the manufacturer. DAPI imaging was performed using 405 nm
for excitation and detection of the fluorescence at 415–475 nm
with a PMT. Both fluorescence measurements were carried out
sequentially for each sample position. Multiple cell images were
acquired as 3D stacks with a resolution of 2,048 × 2,048 pixels
and a step size of 227 nm in x and y direction and five to nine
layers in the z direction with a step size of 570 nm. 3D images of
single cells were acquired with the same objective and a resolution
of 512 × 512 pixels using a step size of 303 nm in the x and y
direction and 570 nm in the z direction.
All data processing was performed using Matlab R2015a. For
comparability of the different samples, all data were preprocessed
as follows: For each 3D measurement, the mean intensity was
calculated in the z direction. For the resulting 2D image,
background noise was reduced by setting all data points with
less than 1% of intensity to this lower threshold. To account for
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cosmic spikes, an upper intensity threshold was set so that less
than 0.1% of the data points showed fluorescence intensity above
this value. Intensities exceeding this upper limit were set to this
value. Images were then rescaled to full range (8-bit) between
these two threshold values.
For statistical analyses, single-cell images were cut from the
mean images using an irregular octagon. For each of these cells,
an intensity histogram analysis was performed. To account for
the different sizes of the single-cell images, the histogram values
were normalized to percentage values. From the analyzed cells per
sample, the mean and standard deviation were calculated on the
normalized histogram data.
Plotting and Statistical Analysis
Data were plotted using GraphPad Prism v.7.0 software
(GraphPad Software, United States) or Origin 6.0 (Origin Lab)
and Adobe Illustrator Artwork 23.0 (Adobe Systems). The
statistical test and method are indicated in the legend of the
figures. p-values of less than 0.05 were considered statistically
significant for all experiments.
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